Antibiotic-resistant Infection
📧 Sign up to get email alerts when something new happens for Antibiotic-resistant Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-12Clinical Trial Update: Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation [Phase 2]
Phase 2 clinical trial on decolonization of antimicrobial-resistant organisms after microbiome perturbation was withdrawn.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. [Phase 2, Phase 3]
A phase 2/3 clinical trial is evaluating an antibiotic-impregnated bone graft to reduce infections in hip replacement surgery, currently rec…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea [Phase 3]
A Phase 3 trial evaluated bismuth subsalicylate for prevention of travelers' diarrhea; the study was terminated and its results have been po…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Inulin for Infections in the Intensive Care Unit [Phase 2]
This release reports results from a Phase 2 trial evaluating inulin for preventing infections and reducing pathogen transmission in ICU pati…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy [Phase 4]
Phase 4 clinical trial assessing the role of postoperative antibiotics in preventing infection after laparoscopic cholecystectomy. The study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-09-04Clinical Trial Update: Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections [Phase 4]
A Phase 4 trial evaluating Imipenem/Cilastatin/Relebactam for carbapenem-resistant Enterobacteriaceae infections has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Optimal Tailored Treatment for H. Pylori Infection [NA]
The clinical trial investigating tailored treatment for Helicobacter pylori infection has been withdrawn. No results are reported.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care
A completed clinical trial focused on enhanced, personalized, and integrated care for infection management at the point of care. Results pos…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization [Phase 1]
Phase 1 trial exploring autologous fecal microbiota transplantation to prevent colonization by antibiotic-resistant bacteria. Completed with…
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial investigating fecal microbiome transplantation in pediatric patients colonized with antibiotic-resistant pathogens pr…
-
CLINICAL_TRIALS research · 2020-01-27Clinical Trial Update: Fecal Microbiota Transplantation for Eradication of CRE [Phase 1, Phase 2]
Clinical trial update on fecal microbiota transplantation to eradicate carbapenem-resistant Enterobacteriaceae (CRE) in Phase 1/2 completed.
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: Digestive Microbiota Transplant
A digestive microbiota transplant trial update sponsored by Assistance Publique Hôpitaux de Marseille; the study status is unknown and it co…
-
CLINICAL_TRIALS research · 2014-12-18Clinical Trial Update: Merck IISP Stewardship Grant for Antibiotic Best Practices
Merck's IISP Stewardship Grant awarded through the University of Wisconsin–Madison to advance antibiotic stewardship practices has completed…